- Nanotechnological Approaches for Mitochondrial Targeting in Neurodegenerative Diseases
- Intermittent Fasting as a Neuroprotective Strategy: Gut-Brain Axis Modulation and Metabolic Reprogramming in Neurodegenerative Disorders
- Development of the Movement Disorders Interpretation Bias Scale and psychometric evaluation in adults with Huntington's disease
- Neural Correlates of Huntington's Disease Based on Electroencephalography (EEG): A Mechanistic Review and Discussion of Excitation and Inhibition (E/I) Imbalance
- Anti-Inflammatory Effects of Cannabinoids in Therapy of Neurodegenerative Disorders and Inflammatory Diseases of the CNS
- The ethics and economics of organoid commercialization: potential donors' perspectives
- Silent destruction: hidden muscle wasting and body decline in early Huntington's disease
- The role of autophagy in the pathogenesis and treatment of multiple sclerosis
- Mitochondrial-Derived Peptides: Implication in the Therapy of Neurodegenerative Diseases
- Alfalfa (Medicago sativa) and neurodegeneration: mechanistic insights into oxidative stress, inflammation, and neuronal survival pathways
- Insulin-like growth factor 2 reduces Huntington's disease aggregates via AKT and NF-kappaB signaling in huntington's disease
- Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases
- Evidence based molecular pathways, available drug targets, pre- clinical animal models and future disease modifying treatments of huntington's disease
- Intrastriatal Delivery of a Zinc Finger Protein Targeting the Mutant HTT Gene Allele Obviates Lipid Phenotypes in Brain and Plasma in Huntington's Disease Mice
- Characterization of psychiatric admissions in Huntington disease: A retrospective review
- Self-driving microscopy detects the onset of protein aggregation and enables intelligent Brillouin imaging
- Variation in the reported prevalence of Huntington's disease: a systematic review and guide to interpretation
- Avocado Oil Prevents Neurological and Behavioral Alterations in a Quinolinic Acid-Induced Model of Huntington's Disease
- Dysregulation of huntingtin interacting protein networks in human juvenile Huntington's disease brain
- The neuroprotective effects of hesperidin and diosmin in neurological disorders via targeting various signaling pathways
- Probing How Anti-huntingtin Antibodies Bind the Fibrillar Fuzzy Coat Using Solid-State NMR
- Targeting ASK1 signaling in neurodegeneration: molecular insights and therapeutic promise
- Balancing Microglial Density and Activation in Central Nervous System Development and Disease
- Longitudinal Investigation of Structural and Resting-State Effective Connectivity Alterations in a Non-Human Primate Model of Huntington's Disease
- Modulation of huntingtin S421 phosphorylation in a Huntington's disease mouse model and its detection in nonhuman primate cerebrospinal fluid
- Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis
- Polyphenolic protection: the role of mangiferin in mitigating neurodegeneration and neuroinflammation
- Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease
- Exploring Methodological Decisions for Calculating the Minimally Detectable Change in Dysarthria: Reliability, Statistics, and Standard Error of Measurement
- Plasma brain-derived tau: analytical and clinical validation of the first commercial immunoassay
- Neuron-derived extracellular vesicles in plasma present a potential non-invasive biomarker for Huntingtin protein and RNA assessment in Huntington disease
- CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential
- Decision tree for severity assessment of neurodegenerative diseases using possibility approach and gait dynamics
- Decoding the Dialogue: Immunity and central nervous system interactions in neurodegenerative diseases
- Juvenile Huntington's Disease: Diagnostic challenges in the Clinic
- Double-edged sword effect of Sutterella in neurological disorders: implications for the gut-brain axis and neuroimmune interactions
- Mapping the Connection Between Circadian Rhythms, Metabolism, and Neurodegeneration: Exploring Therapeutic Strategies
- Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion
- Natural products proposed for the management of Huntington's disease (HD): a comprehensive review
- Combination Supplement Therapy: A New Frontier in Treatment of Neurodegenerative Diseases
- Mitochondria from huntingtons disease striatal astrocytes are hypermetabolic and compromise neuronal branching
- Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntington's disease pathogenesis in mice
- NEDD4L induces mitochondrial dysfunction and neurodegeneration by promoting LIPT2 degradation in Huntington's disease
- Ayurvedic Management of Rare Genetic Condition-Huntington's Chorea: A Case Report
- Neural Networks of Knowledge: Ontologies Pioneering Precision Medicine In Neurodegenerative Diseases
- Mitochondrial Dysfunction in Neurodegenerative Disorders: Role of Prototype Targeted Drug Delivery Solutions
- The Rab3 family proteins in age-related neurodegeneration: unraveling molecular pathways and potential therapeutic targets
- The Digital Frontier in Huntington's Disease: Opportunities for Clinical Trials
- Phenolic Acids Commonly Found in Natural Products Modulate Protein Aggregation in <em>Caenorhabditis elegans</em> Neurodegeneration Models
- Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review
- Oxford Nanopore Third Generation Sequencing for Analysis of FMR1 5'UTR CGG Repeat Expansions
- The diagnosis of Huntington's disease by different molecular tools: a systematic review
- Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice
- Is the Voltage-Dependent Anion Channel a Major Player in Neurodegenerative Diseases?
- The potential of machine learning to personalized medicine in Neurogenetics: Current trends and future directions
- From Brain to Blood: Uncovering Potential Therapeutical Targets and Biomarkers for Huntington's Disease Using an Integrative RNA-Seq Analytical Platform (BDASeq())
- Effect of tetrabenazine on Stroop interference in Huntingtons disease: Pilot Open Label Trial
- Restoring brain barriers: an innovative approach for treating neurological disorders
- Correction: Structural and functional features of medium spiny neurons in the BACHDdeltaN17 mouse model of Huntington's Disease
- Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases
- Potential of MAO-B Inhibitors with Multi-Target Inhibition and Antioxidant Properties for the Treatment of Neurodegenerative Disorders
- From Microbial Homeostasis to Systemic Pathogenesis: A Narrative Review on Gut Flora's Role in Neuropsychiatric, Metabolic, and Cancer Disorders
- Decoding Lymphangioleiomyomatosis (LAM) Niche Environment via Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics
- HTT loss-of-function contributes to RNA deregulation in developing Huntington's disease neurons
- Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
- The Role of Animal Models in Huntington's Disease Clinical Trials: Decoding Genetic, Non-Genetic, and Molecular Pathways
- The role of sensory attenuation in symptomatic and healthy individuals: a scoping review
- When generations meet: navigating nondisclosure preimplantation genetic testing for Huntington's disease
- When Somatic Delusions Meet Cyberchondria: An Unusual Case of Vitamin D Toxicity
- Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases
- Increased translation in adult mouse striatum is sufficient to induce motor dysfunction
- Isoindolinone-Based PET Tracers for Imaging Mutant Huntingtin Aggregates
- Protocol considerations for multigenerational blinding of preimplantation genetic testing for a monogenic condition for Huntington disease: a case report
- Validation of Morphology-Guided Computational Enhancement for Single-Cell Resolution Spatial Transcriptomics
- MicroRNAs in the pathogenesis of neurodegenerative disorders: Potential as therapeutic targets
- Baicalein-mediated regulation of Nrf2/ARE, NFqB, and MAPK signaling in Huntington's disease: a promising strategy against neuroinflammation and neurodegeneration
- Returning of individual genetic findings to biobank participants: a mixed methods study results in Lithuania
- The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders
- Orthosteric inhibition of MutSβ ATPase function: First disclosure of MSH3-bound small molecule inhibitors
- Elucidation of multiple high-resolution states of human MutSβ by cryo-EM reveals interplay between ATP/ADP binding and heteroduplex DNA recognition
- Neurodegenerative Conditions in the Geriatric Population Increase Risk of Distal Radius Fracture: A Nationwide Study
- Proteostasis imbalance: Unraveling protein aggregation in neurodegenerative diseases and emerging therapeutic strategies
- Differential response of neurons to autophagy modulation in Huntington's disease
- Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability
- Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis
- Advancing Inter-brain Synchrony Measurement: A Comparative Hyperscanning Study of High-Density Diffuse Optical Tomography and Functional Near-infrared Spectroscopy
- Barbigerone attenuates 3-nitropropionic acid-induced Huntington's disease-like neuropathology in rats via antioxidant, anti-inflammatory, and neuroprotective mechanisms
- Harnessing Nature's Bounty: The Neuroprotective Potential of Phytoconstituents and Nanotechnology in Neurodegenerative Disease Therapeutics
- Exploring Neurodegenerative Diseases: Bridging the Gap between in vitro and in vivo Models
- Cell-specific mechanisms drive connectivity across the time course of Huntington's disease
- Identification of markers for neurescence through transcriptomic profiling of postmortem human brains
- Microglial immune memory in Parkinson's and Huntington's diseases: epigenetics, triggers, and therapies
- Perspectives on Fecal Microbiota Transplantation: Uses and Modes of Administration
- Nonlinear characteristics of gait signals in neurodegenerative diseases
- The Role and Mechanism of Anti-ICOS mAb in Experimental Autoimmune Encephalomyelitis
- Proteomic profiling of parthanatos and the neuroprotective potential of sodium perborate tetrahydrate
- Research trends of piezoelectric materials in neurodegenerative disease applications
- Nanoliposomal quercetin reduces neuroinflammation and influences TLR4 and microglial activity with potential effects on GABAA2 receptors in a rat model of Huntington's disease
- Multifaceted roles of extracellular vesicles in the interplay of neuroinflammation and neurodegenerative diseases
- Genomic ncRNAs regulating mitochondrial function in neurodegeneration: a neglected clue in the complex etiopathogenesis of multiple sclerosis
